Collaboration Advances Novel Auto-Injector To Meet Patient Needs
Locust Valley, New York and East Hanover, New Jersey: Rx Bandz and Weiss-Aug Co. announced today a strategic partnership to manufacture and supply commercial quantities of Rx Bandz’s MiniJect™ novel epinephrine auto-injector for the treatment of anaphylactic shock.
Under the terms of the partnership, Weiss-Aug will manufacture the MiniJect as Rx Bandz moves towards completing its regulatory submission for FDA approval of the combination therapeutic and delivery device. Once FDA approval is obtained, Weiss-Aug will scale up production of the MiniJect™ to meet the anticipated large unmet need for the MiniJect™.
The MiniJect™ is a patent-protected device that a patient administers in emergency medical conditions, such as anaphylactic shock due to an allergic reaction to food, such as nuts or seafood or an insect sting. The MiniJect™ also offers portability, temperature resistance and other safety features that make it highly attractive for patients. Rx Bandz's auto-injector represents a platform technology capable of delivering many other therapeutics to treat multiple emergency conditions such as hypoglycemia, epilepsy, opioid overdose and chemical weapons exposure.
Financial terms of the partnership were not disclosed.
“We at Rx Bandz could not be happier and prouder to work with Weiss-Aug as our manufacturing and supply partner,” said Jessica Walsh, Rx Bandz’s CEO and founder. “Weiss- Aug is a world-wide leader in precision manufacturing and shares the same commitment to excellence and quality that we have at Rx Bandz.”
“The opportunity to work on this exciting auto-injector technology appealed to us,” said Ken Beller, Vice President of Sales & Marketing at Weiss-Aug. “We pride ourselves on our ability to work on novel and innovative products that meet the most exacting standards for a wide variety of clients across the globe in the fields of medical, automotive and industrial technology.”
ABOUT RX BANDZ LLC
Rx Bandz LLC is a privately held company based in Locust Valley, New York. Rx Bandz is developing the next generation of patient-centric auto-injectors to deliver a wide range of injectable medications for active patients around the world. Designed to treat numerous emergency medical conditions, MiniJect™ will initially focus on delivering epinephrine to treat anaphylactic shock. For more information, see the company’s website at www.rxbandz.com
ABOUT WEISS-AUG CO. INC.
Weiss-Aug provides custom insert molding, precision metal stamping, and assembly solutions. With over 45 years of experience serving the automotive, medical, electronics and semiconductor industries, it excels in design, engineering, tooling and precision manufacturing through innovative design. For more information, see the company’s website at https://www.weiss-aug.com.
コメント